A US-based biotechnology company was considering the introduction of its product into the Chinese healthcare marketplace. Was this a sound business strategy and what were the full implications of such a decision?
The ChinaCareGroup conducted in-depth market research to determine the feasibility, scale and anticipated financial returns associated with the introduction of the company’s product in China. CCG recommended a business strategy and proposed business models for consideration by the board of directors. CCG also assisted the company in its presentations to potential investors.